NYSE:HIMSHealthcare
FTC Data-Sharing Lawsuit Might Change The Case For Investing In Hims & Hers Health (HIMS)
In late July 2026, Hims & Hers Health responded to a lawsuit from the Federal Trade Commission, Utah, and Los Angeles County alleging deceptive subscription practices and improper sharing of sensitive patient data with advertising platforms, firmly rejecting the claims and vowing to defend its telehealth business model and privacy practices.
The company argues the case ignores industry norms and its consent-based data policies, framing the action as headline-driven rather than...